Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Phenotarget Biosciences Inc
Profile last edited on: 7/10/24      CAGE: 8M7Y7      UEI: UM56T2RYWRK9

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2020
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3561 Prince Street Unit A
Escondido, CA 92025
   (858) 480-7468
   N/A
   www.phenotarget.com
Location: Single
Congr. District: 50
County: San Diego

Public Profile

Phenotarget Biosciences, Inc. is structured around development of first-in-class therapeutics as anti-viral treatment of the COVID-19 viral infection. Leveraging technology developed at Texas A&M, Phenotarget has rights to create a peptide-based drug discovery platform that can potentially be applied toward many therapeutic targets for unmet medical needs.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$255,473
Phase II Dollars
$0
Total Awarded
$255,473

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NSF $255,473
Project Title: Discovery and Development of Macrocyclic Peptide Inhibitors of SARS-COV-2 Spike Protein for the Treatment of COVID-19

Key People / Management

  Shoutian Zhu -- Co-Founder and CEO

Company News

There are no news available.